307 related articles for article (PubMed ID: 23649183)
1. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
[TBL] [Abstract][Full Text] [Related]
2. The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM; Denou E; Verdu EF; Bercik P
Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
[TBL] [Abstract][Full Text] [Related]
3. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
O'Malley D; Quigley EM; Dinan TG; Cryan JF
Brain Behav Immun; 2011 Oct; 25(7):1333-41. PubMed ID: 21536124
[TBL] [Abstract][Full Text] [Related]
4. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
5. Treating irritable bowel syndrome with probiotics: the evidence.
Parkes GC; Sanderson JD; Whelan K
Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
[TBL] [Abstract][Full Text] [Related]
6. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.
Ohman L; Simrén M
Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):163-73. PubMed ID: 20101257
[TBL] [Abstract][Full Text] [Related]
8. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
[TBL] [Abstract][Full Text] [Related]
9. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D
Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of enteric neural function in irritable bowel syndrome.
O'Malley D
World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
[TBL] [Abstract][Full Text] [Related]
12. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
[TBL] [Abstract][Full Text] [Related]
13. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
[TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome: is the colonic mucosa to blame?
Hoffman JM
Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
[TBL] [Abstract][Full Text] [Related]
16. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
Piche T
Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
[TBL] [Abstract][Full Text] [Related]
17. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
Elsenbruch S
Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
[TBL] [Abstract][Full Text] [Related]
18. Altered peripheral toll-like receptor responses in the irritable bowel syndrome.
McKernan DP; Gaszner G; Quigley EM; Cryan JF; Dinan TG
Aliment Pharmacol Ther; 2011 May; 33(9):1045-52. PubMed ID: 21453321
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role.
Bolino CM; Bercik P
Infect Dis Clin North Am; 2010 Dec; 24(4):961-75, ix. PubMed ID: 20937460
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
Parkes GC; Brostoff J; Whelan K; Sanderson JD
Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]